[Federal Register: January 16, 2009 (Volume 74, Number 11)]
[Notices]
[Page 3055-3056]
[DOCID:fr16ja09-101]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2008-D-0659]

Draft Guidance for Industry: Current Good Tissue Practice (CGTP)
and Additional Requirements for Manufacturers of Human Cells, Tissues,
and Cellular and Tissue-Based Products (HCT[sol]Ps); Availability

AGENCY:  Food and Drug Administration, HHS.

ACTION:  Notice.

-----------------------------------------------------------------------

SUMMARY:  The Food and Drug Administration (FDA) is announcing the
availability of a draft document entitled ``Guidance for Industry:
Current Good Tissue Practice (CGTP) and Additional Requirements for
Manufacturers of Human Cells, Tissues, and Cellular and Tissue-Based
Products (HCT[sol]Ps)'' dated January 2009. The draft guidance document
provides establishments that manufacture HCT[sol]Ps with
recommendations for complying with CGTP requirements.

DATES:  Although you can comment on any guidance at any time (see 21
CFR 10.115(g)(5)), to ensure that the agency considers your comment on
this draft guidance before it begins work on the final version of the
guidance, submit written or electronic comments on the draft guidance
by April 16, 2009.

ADDRESSES:  Submit written requests for single copies of the draft
guidance to the Office of Communication, Training, and Manufacturers
Assistance (HFM-40), Center for Biologics Evaluation and Research
(CBER), Food and Drug Administration, 1401 Rockville Pike, suite 200N,
Rockville, MD 20852-1448. Send one self-addressed adhesive label to
assist the office in processing your requests. The draft guidance may
also be obtained by mail by calling CBER at 1-800-835-4709 or 301-827-
1800. See the SUPPLEMENTARY INFORMATION section for electronic access
to the draft guidance document.
    Submit written comments on the draft guidance to the Division of
Dockets Management (HFA-305), Food and Drug Administration, 5630
Fishers Lane, rm. 1061, Rockville, MD 20852. Submit electronic comments
to http://www.regulations.gov.

FOR FURTHER INFORMATION CONTACT:  Brenda R. Friend, Center for
Biologics Evaluation and Research (HFM-17), Food and Drug
Administration, 1401 Rockville Pike, suite 200N, Rockville, MD 20852-
1448,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

I. Background

    FDA is announcing the availability of a draft document entitled
``Guidance for Industry: Current Good Tissue Practice (CGTP) and
Additional Requirements for Manufacturers of Human Cells, Tissues, and
Cellular and Tissue-Based Products (HCT[sol]Ps)'' dated January 2009.
This guidance provides establishments that manufacture HCT[sol]Ps with
recommendations for complying with CGTP requirements under part 1271
(21 CFR Part 1271), subpart D (Current Good Tissue Practice), and
requirements under part 1271, subpart E (Additional Requirements for
Establishments Described in Sec.  1271.10). This guidance also
addresses whether the establishment registration and HCT[sol]P listing
requirements under part 1271, subparts A and B apply in certain
instances.
    The draft guidance is being issued consistent with FDA's good
guidance practices regulation (21 CFR 10.115). The draft guidance, when
finalized, will represent FDA's current thinking on this topic. It does
not create or confer any rights for or on any person and does not
operate to bind FDA or the public. An alternative approach may be used
if such approach satisfies the requirement of the applicable statutes
and regulations.

II. Paperwork Reduction Act of 1995

    This draft guidance refers to previously approved collections of
information found in FDA regulations. These collections of information
are subject to review by the Office of Management and Budget (OMB)
under the Paperwork Reduction Act of 1995 (44 U.S.C. 3501-3520). The
collections of information in part 1271, subparts D and E, and
Sec. Sec.  1271.10 and 1271.21 have been approved under OMB Control No.
0910-0543.

III. Commentsuidance is being distributed for comment purposes only and
is not intended for implementation at this time. Interested persons may
submit to the Division of Dockets Management (see ADDRESSES) written or
electronic comments regarding the draft guidance. Submit a single copy
of electronic comments or two paper copies of any mailed comments,
except that individuals may submit one paper copy. Comments are to be
identified with the docket number found in the brackets in the heading
of this document. A copy of the draft guidance and received comments
are available for public examination in the Division of Dockets
Management between 9 a.m. and 4 p.m., Monday through Friday.

    Please note that on January 15, 2008, the FDA Division of Dockets
Management Web site transitioned to the Federal Dockets Management
System (FDMS). FDMS is a Government-wide, electronic docket management
system. Electronic comments or submissions will be accepted by FDA only
through FDMS at http://www.regulations.gov.

IV. Electronic Access

    Persons with access to the Internet may obtain the draft guidance
at either http://www.fda.gov/cber/guidelines.htm or http://
www.regulations.gov.

    Dated: January 13, 2009.
Jeffrey Shuren,
Associate Commissioner for Policy and Planning.
[FR Doc. E9-919 Filed 1-15-09; 8:45 am]

BILLING CODE 4160-01-S


[Federal Register Volume 76, Number 187 (Tuesday, September 27, 2011)]
[Notices]
[Page 59669]
[FR Doc No: 2011-24762]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. IC11-523-000; Docket No. IC11-523-001]

Notice of Commission Information Collection Activities (FERC-
523); Comment Request; Extension Under IC11-523, Notice--Commission
Information Collection Activities (FERC-523); Comment Request;
Submitted for OMB Review Under IC11-523; Errata Notice

    On June 14, 2011, the Commission issued a Notice in Docket No.
IC11-523-000 to solicit public comment on extending the expiration of
an information collection. On August 29, 2011, the Commission issued a
Notice in Docket No. IC11-523-001 regarding its submission of an
information collection to the Office of Management and Budget for
review of information collection requirements. This Errata corrects an
error originating in the June 14 notice and carried into the August 29
notice.

Notice in Docket No. IC11-523-000

    On page 3, in the table, the average burden hours per response
should be changed from 88 to 70.4. This lower figure reflects the
actual estimated burden that was previously approved by OMB and not
used in the table due to an oversight. Changing this figure in the
table necessitates changing the total annual burden hours listed in the
table from 11,669 to 9,363 (rounded).
    On page 4, due to correcting the error on page 3, the first two
sentences should read:

    The estimated total cost to respondents is $640,879 (rounded)
[9,363 hours/2080 hours per year, times $142,372 equals $640,879].
The cost per respondent annually is $8,216 (rounded).

Notice in Docket No. IC11-523-001

    On page 4, in the table, the average burden hours per response
should be changed from 88 to 70.4. This lower figure reflects the
actual estimated burden that was previously approved by OMB and not
used in the table due to an oversight. Changing this figure in the
table necessitates changing the total annual burden hours listed in the
table from 11,669 to 9,363 (rounded).
    Also on page 4, due to the error in the table, the first two
sentences after the table should read:

    The estimated total cost to respondents is $640,879 (rounded)
[9,363 hours/2080 hours per year, times $142,372 equals $640,879].
The cost per respondent annually is $8,216 (rounded).

    Dated: September 14, 2011.
Kimberly D. Bose,
Secretary.
 [FR Doc. 2011-24762 Filed 9-26-11; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register Volume 85, Number 182 (Friday, September 18, 2020)]
[Notices]
[Pages 58348-58349]
[FR Doc No: 2020-20618]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

Combined Notice of Filings #1

    Take notice that the Commission received the following electric
corporate filings:
    Docket Numbers: EC20-59-000.
    Applicants: PurEnergy II, LLC, Orion Acquisitions, LLC.
    Description: Response to August 27, 2020 Deficiency Letter of Orion
Acquisitions, LLC.
    Filed Date: 9/8/20.
    Accession Number: 20200908-5213.
    Comments Due: 5 p.m. ET 9/18/20.

    Take notice that the Commission received the following electric
rate filings:
    Docket Numbers: ER20-644-001.
    Applicants: Southwest Power Pool, Inc.
    Description: Compliance filing: Fast-Start Pricing Practices
Compliance Filing in Response to July 2020 Order to be effective 5/18/
2022.
    Filed Date: 9/14/20.
    Accession Number: 20200914-5065.
    Comments Due: 5 p.m. ET 10/5/20.

    Docket Numbers: ER20-1593-001; ER20- 1596-001; ER20-1597-001; ER20-
1599-001; ER20-1594-001.
    Applicants: Highlander Solar Energy Station 1, LLC, Pleinmont Solar
1, LLC, Pleinmont Solar 2, LLC, Richmond Spider Solar, LLC, Highlander
IA, LLC.
    Description: Notice of Non-Material Change in Status of Highlander
Solar Energy Station 1, LLC, et al.
    Filed Date: 9/11/20.
    Accession Number: 20200911-5339.
    Comments Due: 5 p.m. ET 10/2/20.

    Docket Numbers: ER20-2872-000.
    Applicants: PJM Interconnection, L.L.C.
    Description: Sec.  205(d) Rate Filing: Amendment to ISA, SA No.
5612; Queue No. AF1-185 to be effective 3/10/2020.
    Filed Date: 9/14/20.
    Accession Number: 20200914-5053.
    Comments Due: 5 p.m. ET 10/5/20.

    Docket Numbers: ER20-2873-000.
    Applicants: PJM Interconnection, L.L.C.
    Description: Sec.  205(d) Rate Filing: Amendment to ISA, SA No.
3989; Queue No. Y2-079 to be effective 9/3/2014.
    Filed Date: 9/14/20.
    Accession Number: 20200914-5056.
    Comments Due: 5 p.m. ET 10/5/20.

    Docket Numbers: ER20-2874-000.
    Applicants: Horizon West Transmission, LLC.
    Description: Compliance filing: Horizon West Transmission, LLC
Depreciation Rate Filing to be effective 9/15/2020.
    Filed Date: 9/14/20.
    Accession Number: 20200914-5077.
    Comments Due: 5 p.m. ET 10/5/20.

    Docket Numbers: ER20-2875-000.
    Applicants: Southwest Power Pool, Inc.
    Description: Compliance filing: Compliance Filing in Response to
Order issued in EL19-80-000 to be effective 6/11/2019.
    Filed Date: 9/14/20.
    Accession Number: 20200914-5084.
    Comments Due: 5 p.m. ET 10/5/20.

    Docket Numbers: ER20-2876-000.
    Applicants: PJM Interconnection, L.L.C.
    Description: Sec.  205(d) Rate Filing: Original ISA, SA No. 5749;
Queue No. AB1-105 to be effective 8/18/2020.
    Filed Date: 9/14/20.
    Accession Number: 20200914-5100.
    Comments Due: 5 p.m. ET 10/5/20.

    The filings are accessible in the Commission's eLibrary system
(https://elibrary.ferc.gov/idmws/search/fercgensearch.asp) by querying
the docket number.
    Any person desiring to intervene or protest in any of the above
proceedings must file in accordance with Rules 211 and 214 of the
Commission's Regulations (18 CFR 385.211 and 385.214) on or before 5:00
p.m. Eastern time on the specified comment date. Protests may be
considered, but intervention is necessary to become a party to the
proceeding.
    eFiling is encouraged. More detailed information relating to filing
requirements, interventions, protests, service, and qualifying
facilities filings can be found at: http://www.ferc.gov/docs-filing/efiling/filing-req.pdf. For other information, call<PHONE_NUMBER>
(toll free). For TTY, call<PHONE_NUMBER>.

    Dated: September 14, 2020.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2020-20618 Filed 9-17-20; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register Volume 83, Number 144 (Thursday, July 26, 2018)]
[Notices]
[Pages 35488-35490]
[FR Doc No: 2018-15948]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2018-N-1011]

Agency Information Collection Activities; Submission for Office
of Management and Budget Review; Comment Request; Permanent
Discontinuation or Interruption in Manufacturing of Certain Drug and
Biological Products

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that a
proposed collection of information has been submitted to the Office of
Management and Budget (OMB) for review and clearance under the
Paperwork Reduction Act of 1995.

DATES: Fax written comments on the collection of information by August
27, 2018.

ADDRESSES: To ensure that comments on the information collection are
received, OMB recommends that written comments be faxed to the Office
of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer,
Fax:<PHONE_NUMBER>, or emailed to [email protected]. All
comments should be identified with the OMB control number 0910-0759.
Also include the FDA docket number found in brackets in the heading of
this document.

FOR FURTHER INFORMATION CONTACT: Domini Bean, Office of Operations,
Food and Drug Administration, Three White Flint North, 10A-12M, 11601
Landsdown St., North Bethesda, MD 20852,<PHONE_NUMBER>,
[email protected].

SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has
submitted the following proposed collection of information to OMB for
review and clearance.

Permanent Discontinuation or Interruption in Manufacturing of Certain
Drug and Biological Products--21 CFR 310.306, 314.81(b)(3)(iii), and
600.82

OMB Control Number 0910-0759--Extension

    Sections 310.306, 314.81(b)(3)(iii), and 600.82 (21 CFR 310.306,
314.81(b)(3)(iii), and 600.82) were modified to implement sections 506C
and 506E of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 356c
and 356e) as amended by the Food and Drug Administration Safety and
Innovation Act. Under these sections, applicants with an approved new
drug application (NDA) or abbreviated new drug application (ANDA) for a
covered drug product, manufacturers of a covered drug product marketed
without an approved application, and applicants with an approved
biologics license application (BLA) for a covered biological product
(including certain applications of blood or blood components) must
notify FDA in writing of a permanent discontinuance of the manufacture
of the drug or biological product, or an interruption in manufacturing
of the drug or biological product, that is likely to lead to a
meaningful disruption in the applicant's supply (or a significant
disruption for blood or blood components) of that product. The
notification is required if the drug or biological product is life
supporting, life sustaining, or intended for use in the prevention or
treatment of a debilitating disease or condition, including use in
emergency medical care or during surgery, and if the drug or biological
product is not a radiopharmaceutical drug product.
    The regulations also require that the notification include the
following information: (1) The name of the drug or biological product
subject to the notification, including the National Drug Code Directory
(NDC) (or, for a biological product that does not have an NDC, an
alternative standard for identification and labeling that has been
recognized as acceptable by the Center Director); (2) the name of each
applicant of the drug or biological product; (3) whether the
notification relates to a permanent discontinuance of the drug or
biological product or an interruption in manufacturing of the product;
(4) a description of the reason for the permanent discontinuance or
interruption in manufacturing; and (5) the estimated duration of the
interruption in manufacturing. The notification must be submitted to
FDA electronically at least 6 months prior to the date of the permanent
discontinuance or interruption in manufacturing. If 6 months' advance
notice is not possible because the permanent discontinuance or
interruption in manufacturing was unanticipated 6 months in advance,
the applicant must notify FDA as soon as practicable, but in no case
later than 5 business days after the permanent discontinuance or
interruption in manufacturing occurs.
    If an applicant fails to submit the required notification, FDA will
issue a letter informing the applicant or manufacturer of its
noncompliance. The applicant must submit to FDA, not later than 30
calendar days after FDA issues the letter, a written response setting
forth the basis for noncompliance and providing the required
notification.
    Description of Respondents: Applicants of prescription drugs and
biological products subject to an approved NDA, ANDA, or BLA, and
manufacturers of prescription drug products marketed without an
approved ANDA or NDA, if the product is life supporting, life
sustaining, or intended for use in the prevention or treatment of a
debilitating disease or condition, including use in emergency medical
care or during surgery, or is not a radiopharmaceutical product. If the
BLA applicant is a manufacturer of blood or blood components, it is
only subject to these regulations if it manufactures a significant
percentage of the nation's blood supply.
    Burden Estimates: Based on the number of drug and biological
product shortage related notifications we have seen in the past 12
months, we estimate that annually a total of approximately 75
respondents (``No. of Respondents'' in table 1) will notify us of a
permanent discontinuance of the manufacture of a drug or biological
product or an interruption in manufacturing of a drug or biological
product that is likely to lead to a meaningful disruption in the
respondent's supply of that product. We estimate that these respondents
will submit annually a total of approximately 352.5 notifications as
required under Sec. Sec.  310.306, 314.81(b)(3)(iii), and 600.82. We
estimate 4.7 notifications per respondent, because a respondent may
experience multiple discontinuances or interruptions in manufacturing
in a year that requires notification (``No. of Responses per
Respondent'' in table 1). We also estimate that preparing and
submitting these notifications to FDA will take approximately 2 hours
per respondent (``Average Burden per Response'' in table 1).
    In the Federal Register of April 13, 2018, (83 FR 16108), FDA
published a 60-day notice requesting public comment on the proposed
collection of information. No comments were received.
    We estimate the burden of the information collection as follows:

                                                         Table 1--Estimated Reporting Burden \1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                Number of
                           21 CFR section                               Number of      responses per     Total annual   Average  burden    Total hours
                                                                       respondents       respondent       responses      per  response
--------------------------------------------------------------------------------------------------------------------------------------------------------
Notifications required under Sec.  Sec.   310.306 (unapproved                    75              4.7            352.5                2              705
 drugs), 314.81(b)(3)(iii) (products approved under an NDA or
 ANDA), and 600.82 (products approved under a BLA).................
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.

    The estimated burden for this information collection has changed
since the previous OMB approval. The current burden is based on the
number of actual new notifications received including notifications
that were counted previously under the OMB approval for the interim
final rule entitled ``Permanent Discontinuance or Interruption in
Manufacturing of Certain Drug or Biological Products'' (80 FR 38915,
July 8, 2015) (OMB control number 0910-0699).

    Dated: July 16, 2018.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2018-15948 Filed 7-25-18; 8:45 am]
 BILLING CODE 4164-01-P


[Federal Register Volume 82, Number 104 (Thursday, June 1, 2017)]
[Notices]
[Page 25282]
[FR Doc No: 2017-11273]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. ER17-1672-000]

Supplemental Notice That Initial Market-Based Rate Filing
Includes Request for Blanket Section 204 Authorization: Gulf Coast
Solar Center III, LLC

    This is a supplemental notice in the above-referenced proceeding of
Gulf Coast Solar Center III, LLC's application for market-based rate
authority, with an accompanying rate tariff, noting that such
application includes a request for blanket authorization, under 18 CFR
part 34, of future issuances of securities and assumptions of
liability.
    Any person desiring to intervene or to protest should file with the
Federal Energy Regulatory Commission, 888 First Street NE., Washington,
DC 20426, in accordance with Rules 211 and 214 of the Commission's
Rules of Practice and Procedure (18 CFR 385.211 and 385.214). Anyone
filing a motion to intervene or protest must serve a copy of that
document on the Applicant.
    Notice is hereby given that the deadline for filing protests with
regard to the applicant's request for blanket authorization, under 18
CFR part 34, of future issuances of securities and assumptions of
liability, is June 14, 2017.
    The Commission encourages electronic submission of protests and
interventions in lieu of paper, using the FERC Online links at http://www.ferc.gov. To facilitate electronic service, persons with Internet
access who will eFile a document and/or be listed as a contact for an
intervenor must create and validate an eRegistration account using the
eRegistration link. Select the eFiling link to log on and submit the
intervention or protests.
    Persons unable to file electronically should submit an original and
5 copies of the intervention or protest to the Federal Energy
Regulatory Commission, 888 First Street NE., Washington, DC 20426.
    The filings in the above-referenced proceeding are accessible in
the Commission's eLibrary system by clicking on the appropriate link in
the above list. They are also available for electronic review in the
Commission's Public Reference Room in Washington, DC. There is an
eSubscription link on the Web site that enables subscribers to receive
email notification when a document is added to a subscribed docket(s).
For assistance with any FERC Online service, please email
<EMAIL_ADDRESS>or call<PHONE_NUMBER> (toll free). For
TTY, call<PHONE_NUMBER>.

    Dated: May 25, 2017.
Kimberly D. Bose,
Secretary.
[FR Doc. 2017-11273 Filed 5-31-17; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register Volume 78, Number 32 (Friday, February 15, 2013)]
[Notices]
[Pages 11171-11172]
[FR Doc No: 2013-03596]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[ER-FRL-9007-6]

Environmental Impacts Statements; Notice of Availability

    Responsible Agency: Office of Federal Activities, General
Information<PHONE_NUMBER> or http://www.epa.gov/compliance/nepa/.
Weekly receipt of Environmental Impact Statements
Filed 02/04/2013 Through 02/08/2013
Pursuant to 40 CFR 1506.9.

Notice

    Section 309(a) of the Clean Air Act requires that EPA make public
its comments on EISs issued by other Federal agencies. EPA's comment
letters on EISs are available at: http://www.epa.gov/compliance/nepa/eisdata.html.
EIS No. 20130026, Final EIS, USFWS, TX, Edwards Aquifer Recovery
Implementation Program Habitat Conservation Plan, Review Period Ends:
03/18/2013, Contact: Adam Zerrenner<PHONE_NUMBER>.

EIS No. 20130027, Final EIS, USFWS, AK, Izembek National Wildlife
National Wildlife Refuge Land Exchange/Road Corridor, Review Period
Ends: 03/18/2013, Contact: Stephanie Brady<PHONE_NUMBER>.
EIS No. 20130028, Draft EIS, AFS, AZ, Programmatic--Apache-Sitgreaves
National Forests Land Management Plan, Comment Period Ends: 05/17/2013,
Contact: Michelle Davalos<PHONE_NUMBER>.
EIS No. 20130029, Draft EIS, NPS, 00, Cottonwood Cove and Katherine
Landing Draft Development Concept Plans, Lake Mead National Recreation
Area, NV, AZ, Comment Period Ends: 04/16/2013, Contact: Greg Jarvis
303-969-2263.
EIS No. 20130030, Final EIS, USFS, OR, Mt. Bachelor Ski Area
Improvements Project, Review Period Ends: 03/18/2013, Contact: Amy
Tinderholt<PHONE_NUMBER>.
EIS No. 20130031, Draft EIS, USN, CA, U.S. Navy F-35C West Coast
Homebasing, Comment Period Ends: 04/22/2013, Contact: Amy Kelley 619-
532-2799.
EIS No. 20130032, Final EIS, BLM, CA, Alta East Wind Project, Proposed
Plan Amendment, Comment Period Ends: 03/18/2013, Contact: Jeffery K.
Childers<PHONE_NUMBER>.
EIS No. 20130033, Draft Supplement, USFS, CA, Southern California
National Forests Land Management Plan Amendment, Comment Period Ends:
05/17/2013, Contact: Robert Hawkins<PHONE_NUMBER>.

    Dated: February 12, 2013.
Dawn Roberts,
Management Analyst, Office of Federal Activities.
[FR Doc. 2013-03596 Filed 2-14-13; 8:45 am]
BILLING CODE 6560-50-P


[Federal Register Volume 77, Number 167 (Tuesday, August 28, 2012)]
[Notices]
[Pages 51990-51991]
[FR Doc No: 2012-21139]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

Combined Notice of Filings 2

    Take notice that the Commission received the following electric
rate filings:
    Docket Numbers: ER12-2492-000.
    Applicants: Emera Energy Services Subsidiary No. 6 LLC.
    Description: Application for MBR Authority of Emera Energy Services
Subsidiary No. 6 to be effective 10/20/2012.

    Filed Date: 8/21/12.
    Accession Number: 20120821-5049.
    Comments Due: 5 p.m. ET 9/11/12.

    Docket Numbers: ER12-2493-000.
    Applicants: Emera Energy Services Subsidiary No. 7 LLC.
    Description: Emera Energy Services Subsidiary No. 7 LLC submits
tariff filing per 35.12: Application for MBR Authority of Emera Energy
Services Subsidiary No. 7 to be effective 10/20/2012.
    Filed Date: 8/21/12.
    Accession Number: 20120821-5052.
    Comments Due: 5 p.m. ET 9/11/12.

    Docket Numbers: ER12-2494-000.
    Applicants: Emera Energy Services Subsidiary No. 8 LLC.
    Description: Emera Energy Services Subsidiary No. 8 LLC submits
tariff filing per 35.12: Application for MBR Authority of Emera Energy
Services Subsidiary No. 8 to be effective 10/20/2012.
    Filed Date: 8/21/12.
    Accession Number: 20120821-5053.
    Comments Due: 5 p.m. ET 9/11/12.

    Docket Numbers: ER12-2495-000.
    Applicants: Emera Energy Services Subsidiary No. 9 LLC.
    Description: Emera Energy Services Subsidiary No. 9 LLC submits
tariff filing per 35.12: Application for MBR Authority of Emera Energy
Services Subsidiary No. 9 to be effective 10/20/2012.
    Filed Date: 8/21/12.
    Accession Number: 20120821-5054.
    Comments Due: 5 p.m. ET 9/11/12.

    Docket Numbers: ER12-2496-000.
    Applicants: Emera Energy Services Subsidiary No. 10.
    Description: Emera Energy Services Subsidiary No. 10 submits tariff
filing per 35.12: Application for MBR Authority of Emera Energy
Services Subsidiary No. 10 to be effective 10/20/2012.
    Filed Date: 8/21/12.
    Accession Number: 20120821-5059.
    Comments Due: 5 p.m. ET 9/11/12.
    The filings are accessible in the Commission's eLibrary system by
clicking on the links or querying the docket number.
    Any person desiring to intervene or protest in any of the above
proceedings must file in accordance with Rules 211 and 214 of the
Commission's Regulations (18 CFR 385.211 and 385.214) on or before 5
p.m. Eastern time on the specified comment date. Protests may be
considered, but intervention is necessary to become a party to the
proceeding.
    eFiling is encouraged. More detailed information relating to filing
requirements, interventions, protests, service, and qualifying
facilities filings can be found at: http://www.ferc.gov/docs-filing/efiling/filing-req.pdf. For other information, call<PHONE_NUMBER>
(toll free). For TTY, call<PHONE_NUMBER>.

    Dated: August 21, 2012.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2012-21139 Filed 8-27-12; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register: June 3, 2009 (Volume 74, Number 105)]
[Notices]
[Page 26764-26765]
[DOCID:fr03jn09-128]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

National Highway Traffic Safety Administration

[Docket No. NHTSA-2009-0101]

Notice of Receipt of Petition for Decision That Nonconforming
2006 Porsche Cayenne Multipurpose Passenger Vehicles Manufactured Prior
to September 1, 2006 Are Eligible for Importation

AGENCY: National Highway Traffic Safety Administration, DOT.

ACTION: Notice of receipt of petition for decision that nonconforming
2006 Porsche Cayenne multipurpose passenger vehicles manufactured prior
to September 1, 2006 are eligible for importation.

-----------------------------------------------------------------------

SUMMARY: This document announces receipt by the National Highway
Traffic Safety Administration (NHTSA) of a petition for a decision that
2006 Porsche Cayenne multipurpose passenger vehicles (MPVs)
manufactured prior to September 1, 2006 that were not originally
manufactured to comply with all applicable Federal motor vehicle safety
standards (FMVSS) are eligible for importation into the United States
because: (1) They are substantially similar to vehicles that were
originally manufactured for sale in the United States and that were
certified by their manufacturer as complying with the safety standards
(the U.S.-certified 2006 Porsche Cayenne MPV manufactured prior to
September 1, 2006), and (2) they are capable of being readily altered
to conform to the standards.

DATES: The closing date for comments on the petition is July 6, 2009.

ADDRESSES: Comments should refer to the docket and notice numbers above
and be submitted by any of the following methods:
     Federal eRulemaking Portal: Go to http://
www.regulations.gov. Follow the online instructions for submitting
comments.
     Mail: Docket Management Facility: U.S. Department of
Transportation, 1200 New Jersey Avenue SE., West Building Ground Floor,
Room W12-140, Washington, DC 20590-0001.
     Hand Delivery or Courier: West Building Ground Floor, Room
W12-140, 1200 New Jersey Avenue, SE., between 9 a.m. and 5 p.m. ET,
Monday through Friday, except Federal holidays.
     Fax:<PHONE_NUMBER>.
    Instructions: Comments must be written in the English language, and
be no greater than 15 pages in length, although there is no limit to
the length of necessary attachments to the comments. If comments are
submitted in hard copy form, please ensure that two copies are
provided. If you wish to receive confirmation that your comments were
received, please enclose a stamped, self-addressed postcard with the
comments. Note that all comments received will be posted without change
to http://www.regulations.gov, including any personal information
provided. Please see the Privacy Act heading below.
    Privacy Act: Anyone is able to search the electronic form of all
comments received into any of our dockets by the name of the individual
submitting the comment (or signing the comment, if submitted on behalf
of an association, business, labor union, etc.). You may review DOT's
complete Privacy Act Statement in the Federal Register published on
April 11, 2000 (65 FR 19477-78).
    How to Read Comments submitted to the Docket: You may read the
comments received by Docket Management at the address and times given
above. You may also view the documents from the Internet at http://
www.regulations.gov. Follow the online instructions for accessing the
dockets. The docket ID number and title of this notice are shown at the
heading of this document notice. Please note that even after the
comment closing date, we will continue to file relevant information in
the Docket as it becomes available. Further, some people may submit
late comments. Accordingly, we recommend that you periodically search
the Docket for new material.

FOR FURTHER INFORMATION CONTACT: Coleman Sachs, Office of Vehicle
Safety Compliance, NHTSA<PHONE_NUMBER>).

SUPPLEMENTARY INFORMATION:

Background

    Under 49 U.S.C. 30141(a)(1)(A), a motor vehicle that was not
originally manufactured to conform to all applicable FMVSS shall be
refused admission into the United States unless NHTSA has decided that
the motor vehicle is substantially similar to a motor vehicle
originally manufactured for sale in the United States, certified under
49 U.S.C. 30115, and of the same model year as the model of the motor
vehicle to be compared, and is capable of being readily altered to
conform to all applicable FMVSS.
    Petitions for eligibility decisions may be submitted by either
manufacturers or importers who have registered with NHTSA pursuant to
49 CFR Part 592. As specified in 49 CFR 593.7, NHTSA publishes notice
in the Federal Register of each petition that it receives, and affords
interested persons an opportunity to comment on the petition. At the
close of the comment period, NHTSA decides, on the basis of the
petition and any comments that it has received, whether the vehicle is
eligible for importation. The agency then publishes this decision in
the Federal Register.
    Wallace Environmental Testing Laboratories, Inc. of Houston, Texas
(WETL) (Registered Importer 90-005) has petitioned NHTSA to decide
whether nonconforming 2006 Porsche Cayenne MPVs manufactured prior to
September 1, 2006, are eligible for importation into the United States.
The vehicles which WETL believes are substantially similar are 2006
Porsche Cayenne MPVs manufactured prior to September 1, 2006, that were
manufactured for sale in the United States and certified by their
manufacturer as conforming to all applicable FMVSS.
    The petitioner claims that it carefully compared non-U.S. certified
2006 Porsche Cayenne MPVs manufactured prior to September 1, 2006, to
their U.S.-certified counterparts, and found the vehicles to be
substantially similar with

respect to compliance with most FMVSS.
    WETL submitted information with its petition intended to
demonstrate that non-U.S. certified 2006 Porsche Cayenne MPVs
manufactured prior to September 1, 2006, as originally manufactured,
conform to many FMVSS in the same manner as their U.S. certified
counterparts, or are capable of being readily altered to conform to
those standards.
    Specifically, the petitioner claims that non-U.S. certified 2006
Porsche Cayenne MPVs manufactured prior to September 1, 2006, are
identical to their U.S.-certified counterparts with respect to
compliance with Standard Nos. 102 Transmission Shift Lever Sequence,
Starter Interlock, and Transmission Braking Effect, 103 Windshield
Defrosting and Defogging Systems, 104 Windshield Wiping and Washing
Systems, 106 Brake Hoses, 113 Hood Latch System, 116 Motor Vehicle
Brake Fluids, 118 Power-Operated Window, Partition, and Roof Panel
Systems, 119 New Pneumatic Tires for Vehicles Other than Passenger
Cars, 120 Tire Selection and Rims for Motor Vehicles Other than
Passenger Cars, 124 Accelerator Control Systems, 135 Light Vehicle
Brake Systems, 201 Occupant Protection in Interior Impact, 202 Head
Restraints, 204 Steering Control Rearward Displacement, 205 Glazing
Materials, 206 Door Locks and Door Retention Components, 207 Seating
Systems, 209 Seat Belt Assemblies, 210 Seat Belt Assembly Anchorages,
212 Windshield Mounting, 214 Side Impact Protection, 216 Roof Crush
Resistance, 219 Windshield Zone Intrusion, 225 Child Restraint
Anchorage Systems, and 302 Flammability of Interior Materials.
    Petitioner also contends that the vehicle is capable of being
readily altered to meet the following standards, in the manner
indicated:
    Standard No. 101 Controls and Displays: Inscription of the word
``brake'' on the instrument cluster in place of the international ECE
warning symbol and installation of a U.S.-model speedometer, or
modification of the existing speedometer to conform with the
requirements of this standard.
    Standard No. 108 Lamps, Reflective Devices and Associated
Equipment: Installation of U.S.-model headlamps and tail lamps to meet
the requirements of this standard.
    Standard No. 111 Rearview Mirrors: Installation of a U.S.-model
passenger side rearview mirror, or inscription of the required warning
statement on the face of that mirror on all vehicles not already so
equipped.
    Standard No. 114 Theft Protection: Installation of a supplemental
key warning buzzer, or installation of U.S.-version software on all
vehicles not already so equipped.
    Standard No. 208 Occupant Crash Protection: Installation of a seat
belt warning system that the meets the requirements of this standard.
    The petitioner states that the crash protection system used in
these vehicles consists of dual front airbags, knee bolsters, and
combination lap and shoulder belts at the front outboard seating
positions.
    Standard No. 301 Fuel System Integrity: Inspection of all vehicles
and replacement of any non-U.S.-model fuel system components with U.S.-
model components.
    The petitioner additionally states that a vehicle identification
plate must be affixed to the vehicles near the left windshield post to
meet the requirements of 49 CFR Part 565.
    All comments received before the close of business on the closing
date indicated above will be considered, and will be available for
examination in the docket at the above addresses both before and after
that date. To the extent possible, comments filed after the closing
date will also be considered. Notice of final action on the petition
will be published in the Federal Register pursuant to the authority
indicated below.

    Authority: 49 U.S.C. 30141(a)(1)(A) and (b)(1); 49 CFR 593.8;
delegations of authority at 49 CFR 1.50 and 501.8.

    Issued on: May 27, 2009.
Claude H. Harris,
Director, Office of Vehicle Safety Compliance.
[FR Doc. E9-12842 Filed 6-2-09; 8:45 am]

BILLING CODE 4910-59-P


[Federal Register: March 13, 2009 (Volume 74, Number 48)]
[Notices]
[Page 10908]
[DOCID:fr13mr09-47]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. EL09-37-000]

Arkansas Public Service Commission; Notice of Filing

March 6, 2009.
    Take notice that on February 3, 2009, pursuant to section 292.402
of the Commission's regulations, the Arkansas Public Service Commission
filed on behalf of the Arkansas Electric Cooperative Corp. (AECC) a
Petition for Partial Waiver of certain obligations imposed on AECC and
the Members under Sections 292.303(a) and 292.303(b) of the Code of
Federal Regulations \1\ implementing section 210 of the Public Utility
Regulatory Policies Act of 1978, as amended.
---------------------------------------------------------------------------

    \1\ 18 CFR 292.303(a) and 292.303(b) (2008).
---------------------------------------------------------------------------

    Any person desiring to intervene or to protest this filing must
file in accordance with Rules 211 and 214 of the Commission's Rules of
Practice and Procedure (18 CFR 385.211, 385.214). Protests will be
considered by the Commission in determining the appropriate action to
be taken, but will not serve to make protestants parties to the
proceeding. Any person wishing to become a party must file a notice of
intervention or motion to intervene, as appropriate. Such notices,
motions, or protests must be filed on or before the comment date. On or
before the comment date, it is not necessary to serve motions to
intervene or protests on persons other than the Applicant.
    The Commission encourages electronic submission of protests and
interventions in lieu of paper using the ``eFiling'' link at http://
www.ferc.gov. Persons unable to file electronically should submit an
original and 14 copies of the protest or intervention to the Federal
Energy Regulatory Commission, 888 First Street, NE., Washington, DC
20426.
    This filing is accessible on-line at http://www.ferc.gov, using the
``eLibrary'' link and is available for review in the Commission's
Public Reference Room in Washington, DC. There is an ``eSubscription''
link on the Web site that enables subscribers to receive e-mail
notification when a document is added to a subscribed docket(s). For
assistance with any FERC Online service, please e-mail
<EMAIL_ADDRESS>or call<PHONE_NUMBER> (toll free). For
TTY, call<PHONE_NUMBER>.
    Comment Date: 5 p.m. Eastern Time on April 6, 2009.

Kimberly D. Bose,
Secretary.
 [FR Doc. E9-5433 Filed 3-12-09; 8:45 am]

BILLING CODE 6717-01-P